Japan, July 31 -- GENZYME CORP has got intellectual property rights for 'RECOMBINANT AAV VECTORS EXPRESSING OSTEOPROTECTIVE GENES, INCLUDING HAS2 AND LUBRICIN, USEFUL IN TREATMENT OF OSTEOARTHRITIS AND RELATED JOINT CONDITIONS IN MAMMALS.' Other related details are as follows:
Application Number: JP,2024-158436
Category (FI): A61P19/02,A61K48/00,A61K35/76,C12N15/864,100@Z,C12N15/12,C12N15/54,A61K38/43,A61K38/17
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Sept. 12, 2024
Publication Date: Feb. 6, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....